MYC and hepatocellular carcinoma: Epigenetically induced myc interacting lncRNA 1 (EPIC1) promotes the development of the hepatocellular carcinoma cell cycle by interacting with myc proto-oncogene, bHLH transcription factor (MYC), and overexpression of EPIC1 correlates with a poor prognosis in hepatocellular carcinoma patients [13].